Report: Global biosimilars market could reach $2.5B this year

05/7/2013 | Drug Store News

The global biosimilars market is forecast to expand to $2.5 billion this year, a growth of more than 20% from 2012, according to a report from U.K.-based firm Visiongain. The market could see rapid expansion through 2023 as biosimilar drugs enter the U.S. and European markets. Biosimilar versions of monoclonal antibodies and insulins will record the fastest growth, according to the report, which point to the potential product launches in Europe and the U.S. next year.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations